Insights

RX30 Client Testimonial {video}

March 14, 2016

 

 

Rx30 is a leading national developer and supplier of vertical enterprise software that offers pharmacy management software solutions to the independent, hospital, long-term care and specialty pharmacy markets. Dedicated to the independent pharmacy market for the last 35 years, Rx30 offers a suite of market-leading software solutions to enable prescription filling, pharmacy management and other critical functions for its pharmacist customers.

Winner of the M&A Advisor Awards for M&A Deal of the Year (Over $250M to $500M) in New York!

award2

With representation throughout the Americas, Europe, Africa and Asia, Benchmark International can connect you with the right opportunity. To find out more, visit http://www.benchmarkcorporate.com.

client-testimonials_RX30

 

Americas: Sam Smoot at +1 (813) 898 2350 / [email protected]

Europe: Michael Lawrie at +44 (0) 161 359 4400 / [email protected]

Africa: Anthony McCardle at +27 21 300 2055 / [email protected] 

 

ABOUT BENCHMARK INTERNATIONAL:

Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled over $11 billion in transaction value across various industries from offices across the world. With decades of M&A experience, Benchmark International's transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network as well as the #1 Sell-side Exclusive M&A Advisor in the World by Pitchbook's Global League Tables.

Share This Post
Categories

Get These Insights Delivered Directly To Your Email

Explore our curated collection today and stay ahead of the curve in M&A.

Related Posts
U.S. Private Equity Middle Market UpdateAccording to newly released data from Pitchbook, middle-market private equity (PE) dealmaking in the United States in the first half of 2024 has been stable, with buyouts tracking at $345 billion and the number of deals on pace to hit 3,400 for the entire year. This makes it the third-highest middle-market PE dealmaking year on record (data does not include growth-equity deals and growth-equity platform add-ons). The middle market is companies with enterprise values between $25 million and $1 billion.Benchmark International is a Finalist for 18 M&A Advisor AwardsBenchmark International is a finalist in a total of 18 categories in the 23rd Annual M&A Advisor Awards, presented by The M&A Advisor, including the prestigious recognition as Investment Banking Firm of the Year.
Not Finding What You're Looking For?
Ready to dive into our featured M&A content and gain valuable insights for your business?